General Information of the Compound
| Compound ID |
CP0127677
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[1-(4-ethyl-3-oxo-1,4-benzothiazine-2-carbonyl)piperidin-4-yl]hexadecanamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C32H51N3O3S
|
||||||||||||||||||
| Molecular Weight |
557.845
|
||||||||||||||||||
| Canonical SMILES |
CCCCCCCCCCCCCCCC(=O)NC1CCN(CC1)C(=O)C1Sc2ccccc2N(CC)C1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C32H51N3O3S/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-21-29(36)33-26-22-24-34(25-23-26)31(37)30-32(38)35(4-2)27-19-17-18-20-28(27)39-30/h17-20,26,30H,3-16,21-25H2,1-2H3,(H,33,36)
Show/Hide
|
||||||||||||||||||
| InChIKey |
UCWJRAYZHGNXAV-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00962, Glycogen synthase kinase-3 beta
Cell Viability or Cytotoxicity Assay
| Cell Line ID | Cell Line Name | Cell Line Organism | |
| CL000072 | A2780 | Homo sapiens (Human) | 1 |
| 1 |
IC50 = 3500 nM
|
TI
LI
LO
TS
|
|
|---|---|---|---|